Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis

N. de Rouw; S. Croes; R. Posthuma; D. E. Agterhuis; J. J. A. O. Schoenmaekers; H. J. Derijks; D. M. Burger; A. M. Dingemans; R. ter Heine

doi:10.1016/j.lungcan.2019.01.018

Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis

N. de Rouw^*, S. Croes, R. Posthuma, D. E. Agterhuis, J. J. A. O. Schoenmaekers, H. J. Derijks, D. M. Burger, A. M. Dingemans, R. ter Heine

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	156-158
Number of pages	3
Journal	Lung Cancer
Volume	130
DOIs	https://doi.org/10.1016/j.lungcan.2019.01.018
Publication status	Published - Apr 2019

Keywords

Pemetrexed
Non-small cell lung cancer
Renal impairment
Pharmacokinetics
CANCER

Cite this

de Rouw, N., Croes, S., Posthuma, R., Agterhuis, D. E., Schoenmaekers, J. J. A. O., Derijks, H. J., Burger, D. M., Dingemans, A. M., & ter Heine, R. (2019). Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis. Lung Cancer, 130, 156-158. https://doi.org/10.1016/j.lungcan.2019.01.018

@article{23d20342feb44572b484f67095ab977d,

title = "Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis",

keywords = "Pemetrexed, Non-small cell lung cancer, Renal impairment, Pharmacokinetics, CANCER",

author = "{de Rouw}, N. and S. Croes and R. Posthuma and Agterhuis, {D. E.} and Schoenmaekers, {J. J. A. O.} and Derijks, {H. J.} and Burger, {D. M.} and Dingemans, {A. M.} and {ter Heine}, R.",

year = "2019",

month = apr

doi = "10.1016/j.lungcan.2019.01.018",

language = "English",

volume = "130",

pages = "156--158",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

}

Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis. / de Rouw, N.; Croes, S.; Posthuma, R.; Agterhuis, D. E.; Schoenmaekers, J. J. A. O.; Derijks, H. J.; Burger, D. M.; Dingemans, A. M.; ter Heine, R.

In: Lung Cancer, Vol. 130, 04.2019, p. 156-158.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis

AU - de Rouw, N.

AU - Croes, S.

AU - Posthuma, R.

AU - Agterhuis, D. E.

AU - Schoenmaekers, J. J. A. O.

AU - Derijks, H. J.

AU - Burger, D. M.

AU - Dingemans, A. M.

AU - ter Heine, R.

PY - 2019/4

Y1 - 2019/4

KW - Pemetrexed

KW - Non-small cell lung cancer

KW - Renal impairment

KW - Pharmacokinetics

KW - CANCER

U2 - 10.1016/j.lungcan.2019.01.018

DO - 10.1016/j.lungcan.2019.01.018

M3 - Article

VL - 130

SP - 156

EP - 158

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

ER -

Access to Document

10.1016/j.lungcan.2019.01.018